# US 2025/0049985 A1 · Bone adhesive composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0049985 A1
- Document ID: US20250049985A1
- Status: Published application
- Kind: A1
- Application number: 18/720,043
- Filed: 2022-12-16
- Published: 2025-02-13
- Earliest claimed: 2021-12-17
- Assignees: Inserm (Institut National De La Sante Et De La Recherche Medicale); Centre Hospitalier Universitaire De Lille; Universite De Lille; Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement; Centre National De La Recherche Scientifique; Centrale Lille Institut
- Applicants: Inserm (Institut National De La Santé Et De La Recherche MéDicale); Centre Hospitalier Universitaire De Lille; Universite De Lille; Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement; Centre National De La Recherche Scientifique; Centrale Lille Institut
- Inventors: Mathias SCHLUND; Feng CHAI; Joël LYSKAWA; Joël FERRI
- Web page: https://patentgrep.com/patent/US20250049985A1

## CPC

- A61L 24/0063: {Phosphorus containing materials, e.g. apatite}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

An adhesive composition including a calcium phosphate ceramic selected from tetracalcium phosphate and alpha-tricalcium phosphate, phosphorylated serine, polydopamine, and an aqueous solvent. Also, a kit for preparing the adhesive composition, which includes the calcium phosphate ceramic, phosphorylated serine, and polydopamine and a method for preparing the adhesive composition, as well as the uses thereof.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

An adhesive composition comprising:
a calcium phosphate ceramic selected from tetracalcium phosphate and alpha-tricalcium phosphate, preferably tetracalcium phosphate,
phosphorylated serine,
polydopamine, and
an aqueous solvent.

### Claim 14 (depends on 13)

The composition according to claim 13, wherein the amount of calcium phosphate ceramic is comprised between 50% and 80%, preferably between 60% and 70%, more preferably between 65 and 68% by dry weight.

### Claim 15 (depends on 13)

The composition according to claim 13, wherein the amount of phosphorylated serine is comprised between 20% and 50%, preferably between 30% and 40%, more preferably between 32% and 35% by dry weight.

### Claim 16 (depends on 13)

The composition according to claim 13, wherein the calcium phosphate ceramic/phosphorylated serine dry weight ratio is comprised between 1.5 and 2.5, preferably between 1.7 and 2.3, more preferably between 1.9 and 2.

### Claim 17 (depends on 13)

The composition according to claim 13, wherein the amount of polydopamine is comprised between 1% and 5%, preferably 2% by dry weight.

### Claim 18 (depends on 13)

The composition according to claim 13, wherein the density of the composition is comprised between 2 g/cm3 and 2.2 g/cm3.

### Claim 19 (depends on 13)

The composition according to claim 13, wherein the polydopamine is functionalised with at least one active ingredient selected from antibiotics, osteoinductive molecules and x-ray contrast agents.

### Claim 20 (depends on 13)

A kit for preparing an adhesive composition according to claim 13, comprising:
a calcium phosphate ceramic selected from tetracalcium phosphate and alpha-tricalcium phosphate, preferably tetracalcium phosphate,
phosphorylated serine, and
polydopamine.

### Claim 21 (depends on 20)

The kit according to claim 20, wherein the calcium phosphate ceramic, the phosphorylated serine and the polydopamine are in powder form, preferably the polydopamine is in the form of nanoparticle powder.

### Claim 22 (depends on 13)

A method for preparing an adhesive composition according to claim 13, comprising the following steps:
a) mixing a calcium phosphate ceramic selected from tetracalcium phosphate and alpha-tricalcium phosphate, preferably tetracalcium phosphate, phosphorylated serine and polydopamine in a container,
b) adding a solvent to the previous preparation,
c) recovering the mixture thus formed.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the calcium phosphate ceramic, the phosphorylated serine and the polydopamine are in powder form, preferably the polydopamine is in the form of nanoparticle powder.

### Claim 24 (depends on 13)

The adhesive composition according to claim 13, for its therapeutic use in vivo as a bone adhesive.

### Claim 25 (depends on 13)

A method of treating a bone of a subject in need thereof, comprising applying to the bone of the subject the adhesive composition according to claim 13.
